Newjaisa Technologies Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The P/E Ratio of Newjaisa Technologies Ltd changed from 47.2 on March 2024 to 0 on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Newjaisa Technologies Ltd changed from ₹ 297.54 crore on March 2024 to ₹ 61.17 crore on March 2026 . This represents a CAGR of -40.98% over 3 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Newjaisa Technologies Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore. This represent the decline of -100% The ebitda of Newjaisa Technologies Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore. This represent the decline of -3586% The net profit of Newjaisa Technologies Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ -49.86 crore over 8 quarters. This represents a CAGR of 1110.98% The Dividend Payout of Newjaisa Technologies Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Newjaisa Technologies Ltd

Newjaisa Technologies Limited was originally incorporated as 'Newjaisa Technologies Private Limited', pursuant to a certificate of incorporation dated June 16, 2020 issued by the Registrar of Companies, Central Registration Centre and commenced its business on December 18, 2020.
Subsequently, the Company was converted into public limited company pursuant to shareholders resolution passed at an EGM held on May 04, 2023 and name of the Company was changed from 'Newjaisa Technologies Private Limited' to 'Newjaisa Technologies Limited', and a fresh certificate of incorporation dated June 27, 2023 was issued by the Registrar of Companies, Bangalore, Karnataka. The company is a Technology driven Direct to consumer refurbished IT electronics company providing quality refurbished electronics at significant discount as compared to new products.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Newjaisa Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Newjaisa Technologies Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Newjaisa Technologies Ltd is 55 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Newjaisa Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Newjaisa Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Newjaisa Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 31, 2026, the Newjaisa Technologies Ltd stock price is INR ₹15.55. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Newjaisa Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Newjaisa Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.